The board of the AIM-listed medical cannabis company, Celadon Pharmaceuticals, has resigned en masse after a significant internal dispute with the company’s CEO over an imminent de-listing proposal. The decision
All posts tagged in AIM market
6Articles
The challenges facing AIM, London’s junior stock market, are growing. In 2024 alone, 89 companies left AIM, with notable names such as Hornby opting for private ownership due to regulatory
The activist investor DBay Advisors is set to take Alliance Pharma private with a final, sweetened offer of £362 million. The Isle of Man-based investment firm has increased its cash
Conservative Party donor and billionaire Lord Spencer of Alresford has strengthened his position as the largest shareholder in Chapel Down Group, England’s premier winemaker, amidst declining share performance since its
Lord Ashcroft has called for premium English winemaker Gusbourne to withdraw from London’s junior stock market after unsuccessful attempts to secure a buyer. The company’s shares plummeted more than 40
EMV Capital (AIM:EMVC) has successfully completed an oversubscribed £1.5 million fundraising round at a 15% premium to market price, demonstrating robust shareholder confidence despite challenging market conditions. The deep-tech and
